Renal Cancer - Results from #1980

Application of the ACMG/NSGC genetic referral guidelines for hereditary renal cell carcinoma at the University of Miami, from 2014 to 2017. June 23, 2021

Differences in oncological and toxicity outcomes between programmed cell death-1 and programmed cell death ligand-1 inhibitors in metastatic renal cell carcinoma: A systematic review and meta-analysis. June 23, 2021

Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy. June 22, 2021

Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response. June 22, 2021

Comparison of Different Machine Models Based on Contrast-Enhanced Computed Tomography Radiomic Features to Differentiate High From Low Grade Clear Cell Renal Cell Carcinomas. June 21, 2021

Race/ethnicity and advanced stage of renal cell carcinoma in adults: results from surveillance, epidemiology, and end results program 2007-2015. June 21, 2021

Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma. June 18, 2021

Active surveillance in renal tumors: Clinical and oncological outcomes. June 18, 2021

Germline Variants in Renal Cell Carcinoma Patients - Expert Commentary June 17, 2021

Adrenalectomy During Radical Nephrectomy- Incidence and Oncologic Outcomes from the Canadian Kidney Cancer Information System (CKCis) -A Modern Era, Nationwide, Multicenter Cohort. June 17, 2021

Differential effect of body mass index by gender on oncological outcomes in patients with renal cell carcinoma. June 17, 2021

Real-world Clinical Effectiveness of Lenvatinib/Everolimus in a Heavily Pretreated Advanced/Metastatic Renal Cell Carcinoma Population in the US Community Oncology Setting. June 16, 2021

Gene expression signature correlates with outcomes in metastatic renal cell carcinoma patients treated with everolimus alone or with a vascular disrupting agent. June 16, 2021

Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II. June 15, 2021

Assessment of predictors of renal cell carcinoma progression after nephrectomy at short and intermediate term follow-up and implication on surveillance protocols. June 15, 2021

Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline Part I. June 14, 2021

"Collecting duct carcinoma of the kidney: diagnosis and implications for management". June 14, 2021

Primary Renal Tumour Response in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma: Results from the GETUG-AFU 26 NIVOREN Trial. June 11, 2021

Folate-targeted intraoperative fluorescence, OTL38, in robotic-assisted laparoscopic partial nephrectomy. June 11, 2021

Optimal Surgical Outcome of Minimally Invasive Partial Nephrectomy (MIPN) Based on an Early Postoperative Estimated Glomerular Filtration Rate (eGFR). June 10, 2021

Page 100 of 456